FLAG Therapeutics Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2M
- Investors
-
1
FLAG Therapeutics General Information
Description
Operator of an oncology company intended to develop a dual-acting small molecule for the treatment of Glioblastoma. The company's therapies are based on two investigational product platforms that are Anti-angiogenic/Anti-tubulin (AA/AT) platform and Folate-target Anti-cancer (FTAC) platform that include multiple water-soluble small molecule compounds, enabling doctors to treat multiple cancer types including brain, lung, ovarian and pancreatic.
Contact Information
Website
www.flagtherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 9168 Wooden Road
- Raleigh, NC 27617
- United States
+1 (919) 000-0000
FLAG Therapeutics Timeline
FLAG Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | 01-Jul-2019 | $2M | 00.000 | Completed | Pre-Clinical Trials | |
| 4. Seed Round | 09-Jan-2019 | 00.00 | 00.000 | 000.00 | Completed | Startup |
| 3. Debt - General | 21-Nov-2018 | 00000 | 00000 | Completed | Startup | |
| 2. Grant | 01-Jan-2017 | $1.5M | $250K | Completed | Startup | |
| 1. Debt - General | 06-Mar-2015 | $250K | $250K | Completed | Startup |
FLAG Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed | 0,000,000 | 00.0 | 00.0 | 00 | 00.0 | 00.00 |
FLAG Therapeutics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Frank Sorgi Ph.D | Founder, President & Chief Executive Officer | ||
| Jackie Walling Ph.D | Chief Medical Officer |
FLAG Therapeutics Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Frank Sorgi Ph.D | FLAG Therapeutics | Founder, President & Chief Executive Officer | 000 0000 |
FLAG Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
FLAG Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 |